# Oté Pharma

> Oté Pharma is a VC fund backing Health Care, Manufacturing and Innovation Management. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Mar 2012
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.otepharma.nl/

Oté Pharma is a reliable partner for high quality medical device products such as contact lens solutions, eye drops, nasal sprays.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Manufacturing | 1 | 50% |
| Innovation Management | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Funding Round | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Viopti | Viopti was established in May 2009 to bring to market a range of innovative premium branded products for the contact lens user. The companies lead product is the contactspod, a unique disposable contact lens case that is pre filled with solution and provides the end user with a hygienic option for storing their contact lenses.The company haslicensed the right to use the Polaroid brand across a range of products including eye drops and solutions. Polaroid is an iconic brand recognised and trusted globally.Viopti has been supported technically by IT partners Ote for solutions and regularity control and Wideblue for product development.Contactspod is the world's first, pre-filled, single use contact lens case. Hermetically sealed containing sterile multi-purpose solution, it is perfect when travelling and is ideal for spa's, beauty treatments & active sports.Contactspod is small, compact, convenient to carry around and easy to use. These are significant benefits for the traveller especially when flying, given today's baggage weight restrictions. | $818K |  | Mar 30, 2012 |  |
| Viopti | Viopti was established in May 2009 to bring to market a range of innovative premium branded products for the contact lens user. The companies lead product is the contactspod, a unique disposable contact lens case that is pre filled with solution and provides the end user with a hygienic option for storing their contact lenses.The company haslicensed the right to use the Polaroid brand across a range of products including eye drops and solutions. Polaroid is an iconic brand recognised and trusted globally.Viopti has been supported technically by IT partners Ote for solutions and regularity control and Wideblue for product development.Contactspod is the world's first, pre-filled, single use contact lens case. Hermetically sealed containing sterile multi-purpose solution, it is perfect when travelling and is ideal for spa's, beauty treatments & active sports.Contactspod is small, compact, convenient to carry around and easy to use. These are significant benefits for the traveller especially when flying, given today's baggage weight restrictions. | $344K | Seed | Jul 04, 2011 |  |

2 of 2 investments shown.

## Co-investors
- [Kelvin Capital](https://shizune.co/investors/profile/kelvin-capital) — VC Fund, 2 deals together
- [Lancaster Capital](https://shizune.co/investors/profile/lancaster-capital) — VC Fund, 1 deal together
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 1 deal together
- [Wideblue](https://shizune.co/investors/profile/wideblue) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Oté Pharma invest in?

Oté Pharma invests primarily in Health Care, Manufacturing and Innovation Management startups, most often at Seed and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Oté Pharma last invest?

The most recent investment recorded for Oté Pharma closed in Mar 2012. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co